$8.84
0.121.38%
At close: Aug 14, 5:00 PM EST
$8.72
-0.12-1.36%
After Hours: Aug 13, 4:00 PM EST
Cartesian Therapeutics Inc
RNACNASDAQ
Cartesian Therapeutics Earnings & Forecasts
Cartesian Therapeutics (RNAC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cartesian Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.68 | $-0.73 | $-0.80 | $-0.70 |
| Actual | $0.46 | $-1.46 | $-1.39 | $-1.38 |
| Surprise | +167.7% | -100.0% | -73.8% | -97.1% |
| Revenue | ||||
| Estimate | $162912 | $205912 | $212132 | $226536 |
| Actual | $0 | $78000 | $947000 | $452000 |
| Surprise | -100.0% | -62.1% | +346.4% | +99.5% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.01 | $-1.05 | $-1.13 | $-0.99 |
| Revenue | ||||
| Consensus | $147144 | $238568 | — | — |
